Literature DB >> 12060839

The parvocellular vasotocin system of Japanese quail: a developmental and adult model for the study of influences of gonadal hormones on sexually differentiated and behaviorally relevant neural circuits.

Gian Carlo Panzica1, Jacques Bakthazart, Marzia Pessatti, Carla Viglietti-Panzica.   

Abstract

Vasotocin (VT; the antidiuretic hormone of birds) is synthesized by diencephalic magnocellular neurons projecting to the neurohypophysis. A sexually dimorphic system of VT-immunoreactive (ir) parvocellular elements has been described within the male medial preoptic nucleus (POM) and the nucleus of the stria terminalis, pars medialis (BSTm). VT-ir fibers are present in many diencephalic and extradiencephalic locations, and quantitative morphometric analyses demonstrated their sexually dimorphic distribution in regions involved in the control of different aspects of reproduction. Moreover, systemic or intracerebroventricular injections of VT markedly inhibit the expression of some aspects of male sexual behavior. In adult animals, circulating levels of testosterone (T) have a profound influence on the VT immunoreactivity within BSTm, POM, and lateral septum. Castration markedly decreases the immunoreaction, whereas T-replacement therapy restores a situation similar to the intact birds. We observed no changes in gonadectomized females treated with T. These changes parallel similar changes in male copulatory behavior (not present in castrated male quail, fully expressed in castrated, T-treated males). The restoration by T of the VT immunoreactivity in castrated male quail could be fully mimicked by a treatment with estradiol (E(2)), suggesting that the aromatization of T into E(2) may play a key limiting role in both the activation of male sexual behavior and the induction of VT synthesis. This dimorphism has an organizational nature: administration of E(2) to quail embryos (a treatment that abolishes male sexual behavior) results in a dramatic decrease of the VT immunoreactivity in sexually dimorphic regions. Conversely, the inhibition of E(2) synthesis during embryonic life (a treatment that stimulates the expression of male copulatory behavior in treated females exposed in adulthood to T) results in a malelike distribution of VT immunoreactivity. The VT parvocellular system of the Japanese quail can therefore be considered an accurate marker of the sexual differentiation of brain circuits mediating copulatory behavior and could be a very sensitive indicator of the activity of estrogenlike substances on neural circuits.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12060839      PMCID: PMC1241193          DOI: 10.1289/ehp.02110s3423

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  60 in total

1.  Effect of testosterone on the distribution of vasotocin immunoreactivity in the brain of the zebra finch, Taeniopygia guttata castanotis.

Authors:  T Kimura; K Okanoya; M Wada
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

2.  Effects of testosterone on sexually dimorphic parvocellular neurons expressing vasotocin mRNA in the male quail brain.

Authors:  G Panzica; M Pessatti; C Viglietti-Panzica; R Grossmann; J Balthazart
Journal:  Brain Res       Date:  1999-12-11       Impact factor: 3.252

Review 3.  Social behavior functions and related anatomical characteristics of vasotocin/vasopressin systems in vertebrates.

Authors:  J L Goodson; A H Bass
Journal:  Brain Res Brain Res Rev       Date:  2001-07

4.  Intracerebral sex differences in the vasotocin system in birds: possible implication in behavioral and autonomic functions.

Authors:  A Jurkevich; S W Barth; N Aste; G Panzica; R Grossmann
Journal:  Horm Behav       Date:  1996-12       Impact factor: 3.587

5.  Vasotocinergic innervation of areas containing aromatase-immunoreactive cells in the quail forebrain.

Authors:  J Balthazart; P Absil; C Viglietti-Panzica; G C Panzica
Journal:  J Neurobiol       Date:  1997-07

6.  Sexual dimorphism of arg-vasotocin gene expressing neurons in the telencephalon and dorsal diencephalon of the domestic fowl. An immunocytochemical and in situ hybridization study.

Authors:  A Jurkevich; S W Barth; R Grossmann
Journal:  Cell Tissue Res       Date:  1997-01       Impact factor: 5.249

7.  Estradiol mediates effects of testosterone on vasotocin immunoreactivity in the adult quail brain.

Authors:  C Viglietti-Panzica; J Balthazart; L Plumari; S Fratesi; P Absil; G C Panzica
Journal:  Horm Behav       Date:  2001-12       Impact factor: 3.587

Review 8.  Gender-related changes in the avian vasotocin system during ontogeny.

Authors:  A Jurkevich; R Grossmann; J Balthazart; C Viglietti-Panzica
Journal:  Microsc Res Tech       Date:  2001-10-01       Impact factor: 2.769

9.  Morphometric studies demonstrate that aromatase-immunoreactive cells are the main target of androgens and estrogens in the quail medial preoptic nucleus.

Authors:  N Aste; G C Panzica; P Aimar; C Viglietti-Panzica; N Harada; A Foidart; J Balthazart
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

10.  Sexual behavior in Japanese quail as a test end point for endocrine disruption: effects of in ovo exposure to ethinylestradiol and diethylstilbestrol.

Authors:  K Halldin; C Berg; I Brandt; B Brunström
Journal:  Environ Health Perspect       Date:  1999-11       Impact factor: 9.031

View more
  2 in total

Review 1.  Endocrine disrupters: a review of some sources, effects, and mechanisms of actions on behaviour and neuroendocrine systems.

Authors:  C A Frye; E Bo; G Calamandrei; L Calzà; F Dessì-Fulgheri; M Fernández; L Fusani; O Kah; M Kajta; Y Le Page; H B Patisaul; A Venerosi; A K Wojtowicz; G C Panzica
Journal:  J Neuroendocrinol       Date:  2012-01       Impact factor: 3.627

Review 2.  Sexual differentiation of central vasopressin and vasotocin systems in vertebrates: different mechanisms, similar endpoints.

Authors:  G J De Vries; G C Panzica
Journal:  Neuroscience       Date:  2005-11-28       Impact factor: 3.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.